26 results on '"Calvo, Veronica"'
Search Results
2. Abstract P33: Leveraging probabilistic causal disease models to understand molecular pathways and target resistance mechanisms in Multiple Myeloma with the CREBBP and EP300 bromodomain inhibitor, pocenbrodib
3. Supplementary Figure S2 from A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells
4. Supplementary Table S3 from A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells
5. PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors
6. Suppression of the Integrated Stress Response in Islet β Cells Decreases Risk of Autoimmune Diabetes
7. Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment.
8. Abstract 4010: Inhibition of PERK by HC-5404 sensitizes clear cell renal cell carcinoma tumor models to anti-angiogenic tyrosine kinase inhibitors
9. Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors
10. Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors
11. PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells
12. TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion
13. Effect of Oligonucleotide IMT504 in a Type I Diabetes Model Induced by Multiple Low Doses of Streptozotocin in Mice
14. Left ventricular puncture during thoracentesis
15. The Role of Antioxidants in the Treatment of Congenital CMV‐Related Hearing: A Case‐Control Study
16. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments
17. Abstract A38: A PERK inhibitor that blocks HER2-driven tumorigenesis and suppresses metastasis by targeting single disseminated tumor cells
18. Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment
19. Epithelial Xbp1 Is Required for Cellular Proliferation and Differentiation during Mammary Gland Development
20. Abstract 4311: Defining the GRB7 interactome in triple-negative breast cancer.
21. Abstract A54: TACE-regulated TGF-alpha shedding drives GRB7-dependent invasion in triple-negative breast cancer cell lines
22. Visualizing movement in the tumor microenvironment landscape
23. Abstract C156: GRB7 is required for triple-negative breast cancer motility, invasion, and chemoresistance.
24. Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice.
25. Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice.
26. A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.